rvb rvb rvb rvb rvb
THERAPY: RATIONALES FOR NURSING
rvb rvb rvb rvb
rvb PRACTICE, 13TH EDITION (FRANDSEN,
rvb rvb rvb
2025), CHAPTER 1-61 | ALL CHAPTERS
rvb rvb rvb rvb rvb rvb
, Test rvbvBank rvbvFor rvbv Abrams’ rv bv Clinical rvbv Drug rvbv Therapy rvbvRationales rv bv for rvbvNursing
rvbv Practice rvbv 13th rvbv Editionrvb
Table rvbvof rvbvContent
SECTION rvbv1 rvbvThe rvbvConceptual rvbvFramework rvbvof
rvbv Pharmacology rvbvChapter rvbv1 rvbvThe rvbvFoundation rvbvof
rvbv Pharmacology: rvbvQuality rvbvand rvbvSafetyvbC
r hapter rvbv2 rvbvBasic
rvbv Concepts rvbvand rvbvProcesses
Chapter rvbv3 rvbvMedication rvbvAdministration rvbvand rvbvthe rvbvNursing rvbvProcess rvbvof rvbvDrug rvbvTherapy
SECTION rvbv2 rvbvDrug rvbvTherapy rvbvThroughout rvbvthe rvbvLifespan
Chapter rvbv4 rvbvPharmacology rvbvand rvbvthe rvbvCare rvbvof rvbvInfants rvbvand rvbvPediatric rvbvPatients rvbvMedication
Administration rvbvinrvbPediatrics
rvbv
Chapter rvbv5 rvbvPharmacology rvbvand rvbvthe rvbvCare rvbvof rvbvAdults rvbvand
rvbv Geriatric rvbvPatients rvbvChapter rvbv6 rvbvPharmacology rvbvand rvbvthe rvbvCare
rvbv of rvbvPregnant rvbvor rvbvLactating rvbvWomanrvbChapter rvbv7 rvbvPharmacology
rvbv and rvbvWomen’s rvbvHealth
Chapter rvbv8 rvbvPharmacology rvbvand rvbvMen’s rvbvHealth
SECTION rvbv3 rvbvDrugs rvbvAffecting rvbvthe rvbvHematopoietic rvbvand rvbvImmune rvbvSystems
Chapter rvbv9 rvbvDrug rvbvTherapy rvbvfor rvbvCoagulation
rvbv DisordersrvbChapter rvbv10 rvbvDrug rvbvTherapy rvbvfor
rvbv Dyslipidemia
Chapter rvbv11 rvbvDrug rvbvTherapy rvbvfor rvbvHematopoietic
rvbv DisordersrvbChapter rvbv12 rvbvDrug rvbvTherapy:
rvbv Immunizations
Chapter rvbv13 rvbvDrug rvbvTherapy rvbvto rvbvDecrease
, Immunity rvbvChapter rvbv14 rvbvDrug rvbvTherapy rvbvfor
rvbv
the rvbvTreatment rvbvof rvbvCancer
rvbv
, SECTION rvbv4 rvbv Drugs rv bv Affecting rv bv Inflammation rvbv and rvbv Infection
Chapter rvbv15 rvbvInflammation, rvbvInfection, rvbvand rvbvthe rvbvUse rvbvof
rvbv Antimicrobial rvbvAgentsrvbChapter rvbv16 rvbvDrug rvbvTherapy rvbvto rvbvDecrease
rvbv Pain, rvbvFever, rvbvand rvbvInflammation rvbvChapter rvbv17 rvbvDrug rvbvTherapy
rvbv With rvbvCorticosteroids
Chapter rvbv18 rvbvDrug rvbvTherapy rvbvWith rvbvBeta-Lactam rvbvAntibacterial
rvbv Agents rvbvChapter rvbv19 rvbvDrug rvbvTherapy rvbvWith rvbvAminoglycosides
rvbv and rvbvFluoroquinolones
Chapter rvbv20 rvbvDrug rvbvTherapy rvbvWith rvbvTetracyclines, rvbvSulfonamides, rvbvand rvbvUrinary
rvbv Antiseptics rvbvChapter rvbv21 rvbvDrug rvbvTherapy rvbvWith rvbvMacrolides rvbvand
rvbv Miscellaneous rvbvAnti-infective rvbvAgents rvbvChapter rvbv22 rvbvDrug rvbvTherapy rvbvfor
rvbv Tuberculosis rvbvand rvbvMycobacterium rvbvavium rvbvComplex rvbvDiseaservbChapter rvbv23
rvbv Drug rvbvTherapy rvbvfor rvbvViral rvbvInfections
Chapter rvbv24 rvbvDrug rvbvTherapy rvbvfor rvbvFungal
rvbv Infections rvbvChapter rvbv25 rvbvDrug rvbvTherapy
rvbv for rvbvParasitic rvbvInfections
SECTION rvbv5 rvbvDrugs rvbvAffecting rvbvthe rvbvCardiovascular rvbvSystem
Chapter rvbv 26 rvbv Drug Therapy
rvbv for
rvbv
rvbv Hypertension Chapter
b
rv rvbv 27 rvbv Drug
Therapy rvbvfor rvbvDysrhythmias
rvbv
Chapter rvbv 28 Drug
rvbv rvbv Therapy rvbv for Coronary
rvbv
rvbv Heart Disease C
rvbv b hapter
rv 29
rvbv Drug
rvbv rvbv Therapy
rvbv for Shock
rvbv rvbv and rvbvHypotension C
b hapter
rv 30
rvbv
rvbv Drug rvbvTherapy rvbvfor rvbvHeart rvbvFailure